当前位置: 首页 > 期刊 > 《现代养生·下半月》 > 2018年第9期
编号:13337754
应用Robust rank aggregation法筛选肝癌的差异表达关键基因(3)
http://www.100md.com 2018年9月1日 《现代养生·下半月》 2018年第9期
     [15]Shibata R, Mori T, Du W, etal. Overexpression of cyclase-associated protein 2 in multistagehepatocarcinogenesis [J] .

    ClinCancer Res, 2006,12 (18): 5363-5368.

    [16]Lu M, Huang X, Chen Y, et al.Aberrant KIF20A expression mightindependently predict pooroverall survival and recurrence-free survival of hepatocellularcarcinoma [J] . IUBMB Life,2018, 70 (04): 328-335.

    [17]Kijima H, Sawada T, TomosugiN,et al. Expression of hepcidinmRNA is uniformly suppressed inhepatocellular carcinoma [J]. BMCCancer, 2008, 8: 167.

    [18]Critelli R, Milosa F, FaillaciF, et al. Microenvironmentinflammatory infiltrate drivesgrowth speed and outcome ofhepatocellular carcinoma: aprospective clinical study [Jl.Cell Death Dis, 2017, 8 (08) : e3017.

    [19] Hu K, Wang ZM, Li JN, et al.CLECIB Expression and PD-Ll Expression Predict ClinicalOutcome in HepatocellularCarcinomawithTumorHemorrhage [J] .

    Transl Oncol,2018,11(02): 552-558.

    [20]Ho DW, Kai AK, Ng IO. TCGA whole-transcriptome sequencing datareveals significantly dysregulatedgenes and signaling pathways inhepatocellular carcinoma [J]. FrontMed, 2015, 9 (03) : 322-330.

    [21]Luo JH, Ren B, Keryanov S, etal. Transcriptomic and genomicanalysis of human hepatocellularcarcinomas and hepatoblastomas [J].Hepatology, 2006, 44 (04): 1012-1024., http://www.100md.com(范振海 邢时云 冯源)
上一页1 2 3